FATE
Fate Therapeutics Inc
2.10$
-0.9%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 67.0% | 65.5% | 69.2% | 60.4% | 62.7% | 66.2% | 62.3% | 62.0% | 64.4% | 65.4% | 63.0% | 60.7% | |
| 6.1% | 8.3% | 21.3% | 7.0% | 7.7% | 8.2% | 11.3% | 11.1% | 11.8% | 14.6% | 13.9% | 12.5% | |
| 64.3% | 62.3% | 67.3% | 57.7% | 60.0% | 63.3% | 60.3% | 60.0% | 62.7% | 63.9% | 61.4% | 59.1% | |
| 0.3% | 0.4% | 0.2% | 0.2% | 0.8% | 0.8% | 0.6% | 0.4% | 0.2% | 0.3% | 0.2% | 0.3% | |
| 0.0% | – | – | -2.2% | – | – | – | – | – | – | – | – | |
| 25.9% | 27.2% | 25.2% | 24.9% | 26.8% | 27.7% | 27.7% | 29.7% | 31.9% | 35.0% | 36.9% | 41.0% | |
| 7.6% | 7.7% | 8.0% | 6.6% | 7.6% | 8.7% | 7.1% | 7.7% | 8.2% | 11.3% | 10.8% | 12.5% | |
| 1.1% | 1.2% | 1.1% | 1.3% | 1.4% | 1.7% | 1.6% | 1.5% | 1.4% | 1.4% | 1.7% | 1.9% | |
| 1.0% | 0.9% | 1.2% | 1.0% | 1.3% | 2.1% | 1.1% | 1.1% | 1.0% | 0.8% | 1.2% | 1.3% | |
| 74.1% | 72.8% | 74.8% | 75.1% | 73.2% | 72.3% | 72.3% | 70.3% | 68.1% | 65.0% | 63.1% | 59.0% | |
| -214.7% | -239.4% | -221.0% | -245.5% | -271.9% | -317.2% | -360.1% | -395.5% | -437.0% | -481.1% | -549.5% | -613.5% | |
| 18.1% | 19.5% | 17.7% | 22.2% | 23.8% | 26.7% | 29.7% | 31.9% | 34.6% | 37.2% | 42.1% | 46.3% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.